Study ends debate over role of steroids in treating septic shock

January 19, 2018, George Institute for Global Health

The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

Researchers at The George Institute for Global Health studied whether the use of as an additional treatment to - a severe life threatening infection - would improve survival.

In the results published in the New England Journal of Medicine they found steroids not only reduced the duration of septic shock, but also the time spent on life support therapy in . However, the use of steroids did not lead to fewer deaths overall compared to not receiving steroids.

Lead author Professor Bala Venkatesh, of The George Institute for Global Health, said: "Our results show there is still a lot to learn about septic shock which kills up to half of those affected in some parts of the world. There are undoubtedly many other contributors to survival which we don't yet understand.

"But, we have finally shown what part steroids play in the treatment of these patients. If we can reduce the time in spent in intensive care units that not only frees up space for other patients, it saves worldwide a huge amount of money."

Steroids have been used for over 50 years to treat septic shock - a life threatening illness that occurs when the body's response to infection leads to low blood pressure that reduces blood flow to vital organs and tissues such as the heart, brain, kidney and liver. Steroids are thought to improve the circulation by counteracting the severe inflammation seen in septic shock. However, there was uncertainty about the optimal dose and duration of steroids and concerns that steroids may result in adverse complications to patients.

In this international trial conducted in 3800 patients in Australia, New Zealand, the UK, Denmark and Saudi Arabia, researchers showed that while the use of steroids did not reduce death rates, steroids led to a more rapid resolution of shock, were taken off mechanical ventilation earlier, received less blood transfusions and were discharged from intensive care earlier than those patients who did not receive steroids.

The trial will add high-quality evidence about the safe and effective use of steroids for patients with septic shock.

Co-author Professor John Myburgh, of The George Institute for Global Health, said: "Anyone can get sepsis, young, old, fit and healthy. It does not discriminate. Those that survive can be left with substantial injuries such as amputated limbs, and .

"It is essential that we raise awareness of this disease so people can get treatment more quickly, but we will also need to find better and more effective care for those who go into septic shock."

Explore further: Steroids prescribed in the ICU linked to delirium

Related Stories

Steroids prescribed in the ICU linked to delirium

May 27, 2014
New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest ...

Diabetes insipidus can occur after stopping vasopressin

September 23, 2017
(HealthDay)—Although rare, diabetes insipidus (DI) can occur following discontinuation of vasopressin infusion for septic shock, according to a case study published online Sept. 11 in the Journal of Clinical Pharmacy & ...

Septic shock patients have better outcomes when their heart rates are lower, study finds

October 4, 2016
Researchers at Intermountain Medical Center in Salt Lake City, along with researchers from four other centers, including Harvard Medical School, have found that patients with a lower heart rate who are in septic shock have ...

Machine learning may help in early identification of severe sepsis

May 24, 2017
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records (EHRs), according to a study presented at the 2017 American ...

Study compares treatments to improve kidney outcomes for patients with septic shock

August 2, 2016
Early use of vasopressin to treat septic shock did not improve the number of kidney failure-free days compared with norepinephrine, according to a study appearing in the August 2 issue of JAMA.

Pitt leads sepsis care guidance in preparation for nationwide hospital requirements

August 18, 2015
As hospitals nationwide brace for rigorous mandates for care of septic patients that will be adopted by the Centers for Medicare & Medicaid Services in October, a University of Pittsburgh School of Medicine review unveils ...

Recommended for you

Largest oral HPV study in England shows infection rates lower than expected

August 20, 2018
Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.